Showing results (1-10 of 64) with videos related to
Sort By:
Pageof 7
Clinical Calcium|January 8, 2008
[Basic and clinical aspects of calcimimetics. The pathogesis and treatment of secondary hyperparathyroidism]Masahide Mizobuchi, Tadao AkizawaClinical Calcium|October 2, 2012
[Phosphate sensing and parathyroid gland]Masahide Mizobuchi, Taihei SuzukiCurrent Vascular Pharmacology|May 30, 2013
Clinical uses of 22-oxacalcitriolMasahide Mizobuchi, Hiroaki OgataClinical Calcium|November 27, 2014
[New Developments in CKD-MBD. Future perspective of calcimimetics]Masahide Mizobuchi, Takashi InoueJournal of the American Society of Nephrology : JASN|May 30, 2009
Vascular calcification: the killer of patients with chronic kidney diseaseMasahide Mizobuchi, Dwight Towler, Eduardo SlatopolskyClinical Calcium|June 30, 2010
[CKD-MBD (chronic kidney disease-mineral and bone disorder). CKD-MBD: chronic kidney disease-mineral and bone disorder]Masahide Mizobuchi, Yumie Aoshima, Tadao AkizawaClinical Calcium|February 3, 2009
[Novel phosphate binders under development]Masahide Mizobuchi, Daisuke Sanada, Tadao AkizawaClinical Calcium|December 3, 2011
[Bone and calcium update; diagnosis and therapy of metabolic bone disease update. Advances in treatment of CKD-MBD]Masahide Mizobuchi, Ai Nakazawa, Tadao AkizawaExpert Opinion on Investigational Drugs|June 27, 2014
Is there a need for new phosphate binders to treat phosphate imbalance associated with chronic kidney disease?Jinshyun Ruth Wu-Wong, Masahide MizobuchiTherapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|November 10, 2018
Secondary Hyperparathyroidism: Pathogenesis and Latest TreatmentMasahide Mizobuchi, Hiroaki Ogata, Fumihiko KoiwaPageof 7